AUMdb

Mpm Asset Management Llc

SEC-registered Private Fund Manager · Mid-sized ($1B–$10B) CRD 148467 · SEC file 801-106989 · Boston, MA · www.linkedin.com
☆ Save with Pro ADV data as of Apr 28, 2026
Regulatory AUM
$3.6B
Discretionary
$3.6B
Clients
23
Avg AUM / client
$155M
Accounts
23
Employees
50

AUM over time

$1.0B $3.6B
Nov 2015 Dec 2025

Annual snapshots from Form ADV filings · as of Apr 28, 2026

Who they serve

Client typeClientsAUM% of AUM
Pooled investment vehicles (non-investment companies) 23 $3.6B 100.0%

Private funds (21)

View all →

Reported in Form ADV Section 7.B.(1), filing of Jun 2024 · $3.3B combined gross assets

FundTypeDomicileGross assetsOwners
Oncology Impact Fund 2, L.P. master Other Private Fund Cayman Islands $826M 32
Ubs Oncology Impact Fund L.P. master Other Private Fund Cayman Islands $721M 660
Mpm Bioventures 2018, L.P. Venture Capital Fund Delaware $653M 43
Mpm Bioventures 2022, L.P. Venture Capital Fund Delaware $345M 40
Mpm Oncology Innovations Fund L.P. Venture Capital Fund Delaware $170M 36
Bioimpact Equities Fund, Lp Hedge Fund Delaware $154M 40
Mpm Bioventures 2014, L.P. Venture Capital Fund Delaware $148M 61
Bioimpact Equities Master Fund, Lp master Hedge Fund Cayman Islands $99.0M 11
Mpm Bioventures Iv Qp, L.P. Venture Capital Fund Delaware $52.5M 68
Mpm Bioventures 2018 (B), L.P. Venture Capital Fund Delaware $33.9M 8
Mpm Bioventures V, L.P. Venture Capital Fund Delaware $20.4M 29
Mpm Asset Management Investors Bv2018 Llc Venture Capital Fund Delaware $13.6M 24
Mpm Bioventures 2014 (B), L.P. Venture Capital Fund Delaware $9.7M 13
Mpm Bio Iv Nvs Strategic Fund, L.P. Venture Capital Fund Bermuda $7.3M 2
Mpm Bio 2014 Nvs Strategic Fund, L.P. Venture Capital Fund Bermuda $7.2M 2

People (8)

NameRole / titleCredentialsWith firm sinceOwnership
Evnin, Luke, Basil Senior Advisor Dec 1999 (27y) ≈ 18.75% – 56.25% via Mpm Founders Llc
Gadicke, Ansbert, Karl Managing Director Jan 2012 (15y) 25% – 50%
Paul N Karger Trustee CFA Jan 2015 (12y) GP / trustee / elected manager of Ansbert K. Gadicke 2015 Irrevocable Trust Ii (indirect)
Bardon, Christiana, Goh Trustee Nov 2015 (11y) GP / trustee / elected manager of Ansbert K. Gadicke 2015 Irrevocable Trust Ii (indirect)
Foley, Todd, Thomas Managing Director Nov 2015 (11y) Less than 5%
Laguerre, Kristen, Lee Partner, Finance And Operations Oct 2019 (7y) Less than 5%
Furey, Brendan, Michael Chief Compliance Officer Nov 2022 (4y) Less than 5%
Risoleo, Robert, Samuel General Counsel Jan 2024 (3y) Less than 5%

Entity owners (Schedule A/B)

EntityTitle / statusSinceSch.Ownership
Mpm Capital Llc Member Nov 2015 A 50% – 75%
Mpm Founders Llc Member Dec 1999 B ≈ 37.5% – 75% via Mpm Capital Llc
Gadicke 2012 Irrevocable Trust Member Nov 2015 B ≈ 9.38% – 37.5% via Mpm Founders Llc
Ansbert K. Gadicke 2015 Irrevocable Trust Ii Member Nov 2015 B ≈ 9.38% – 37.5% via Mpm Founders Llc

Undisclosed: 0% – 25% of the firm is not attributable from the filed Schedule A bands.

Estimated effective ownership (look-through of filed bands):

  • Evnin, Luke, Basil: 50% – 75% of Mpm Founders Llc × 75% – 100% of Mpm Capital Llc × 50% – 75% direct ≈ 18.75% – 56.25% of the firm
  • Mpm Founders Llc: 75% – 100% of Mpm Capital Llc × 50% – 75% direct ≈ 37.5% – 75% of the firm
  • Gadicke 2012 Irrevocable Trust: 25% – 50% of Mpm Founders Llc × 75% – 100% of Mpm Capital Llc × 50% – 75% direct ≈ 9.38% – 37.5% of the firm
  • Ansbert K. Gadicke 2015 Irrevocable Trust Ii: 25% – 50% of Mpm Founders Llc × 75% – 100% of Mpm Capital Llc × 50% – 75% direct ≈ 9.38% – 37.5% of the firm

Roster from the IAPD representatives feed; ownership and acquisition dates from Form ADV Schedule A/B. "Since" is the earliest filed registration or acquisition date.

Private funds (21, $3.3B gross assets)

FundTypeGross assetsMin. investmentOwners
Oncology Impact Fund 2, L.P. Other Private Fund $826M $5.0M 32
Ubs Oncology Impact Fund L.P. Other Private Fund $721M $5.0M 660
Mpm Bioventures 2018, L.P. Venture Capital Fund $653M $100K 43
Mpm Bioventures 2022, L.P. Venture Capital Fund $345M $3.0M 40
Mpm Oncology Innovations Fund L.P. Venture Capital Fund $170M $250K 36
Bioimpact Equities Fund, Lp Hedge Fund $154M $1.0M 40
Mpm Bioventures 2014, L.P. Venture Capital Fund $148M $100K 61
Bioimpact Equities Master Fund, Lp Hedge Fund $99.0M $1.0M 11
Mpm Bioventures Iv Qp, L.P. Venture Capital Fund $52.5M $100K 68
Mpm Bioventures 2018 (B), L.P. Venture Capital Fund $33.9M $200K 8
Mpm Bioventures V, L.P. Venture Capital Fund $20.4M $100K 29
Mpm Asset Management Investors Bv2018 Llc Venture Capital Fund $13.6M $38.0K 24
Mpm Bioventures 2014 (B), L.P. Venture Capital Fund $9.7M $50.0K 13
Mpm Bio Iv Nvs Strategic Fund, L.P. Venture Capital Fund $7.3M $100M 2
Mpm Bio 2014 Nvs Strategic Fund, L.P. Venture Capital Fund $7.2M $100K 2
Mpm Asset Management Investors Bv2014 Llc Venture Capital Fund $6.7M $5.0K 26
Mpm Bio V Nvs Strategic Fund, L.P. Venture Capital Fund $5.1M $100K 2
Mpm Asset Management Investors Bv4 Llc Venture Capital Fund $3.3M $10.0K 28
Mpm Asset Management Investors Bv5 Llc Venture Capital Fund $1.9M $15.0K 22
Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg Venture Capital Fund $1.6M $15.0M 2
Oncology Investors Of Texas Costim, Llc Venture Capital Fund $947K $100K 8

From Form ADV Section 7.B private fund reporting.

Documents (1 archived)

FormPeriodSize
Form ADV (full filing) 04/28/2026 4.67 MB View · PDF · Source ↗

Archived copies of the firm's regulatory filings, versioned by content hash.

Disciplinary disclosures

No disciplinary events reported on the firm's latest Form ADV filing.

How they charge

  • Percentage of assets under management
  • Performance-based fees
  • Other fees
  • CARRIED INTEREST

Services

  • Portfolio management for pooled investment vehicles

Custody

Firm reports having custody of client funds or securities (Item 9.A).

No custodian data reported or mined yet.

Source

All data on this page comes from this firm's Form ADV filings, reproduced without modification. Latest filing: Apr 28, 2026.

View current Form ADV (SEC/IAPD) ↗